Clinical Trial Update: As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update on an as-needed beclomethasone/salbutamol combination inhaler for mild persistent asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclomethasone/salbutamol combination inhaler

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED